When you are trying to conceive, blood tests become part of the landscape. Low AMH and high FSH often raise unnecessary fears about future fertility.
They can be clinically important. They can affect treatment planning and, depending on your age, menstrual history and wider fertility picture, they can make time more important. But they answer different biological questions. Neither result establishes that a follicle cannot mature, ovulate, be fertilised or lead to pregnancy.
What AMH actually measures — and why it is not a measure of ovarian reserve
AMH is commonly described as an ovarian reserve test. In practice, it is not a direct measure of how many eggs remain.
Ovarian reserve is a theoretical concept. It refers to the number of oocytes remaining in the ovary. It cannot be directly measured — only inferred.
AMH is produced by granulosa cells of small growing follicles. It tells us how the ovary is behaving right now and how it is likely to respond to stimulation in IVF. It does not measure egg quality, or how likely pregnancy is in a given cycle.
AMH tells us how the ovary is behaving right now — not how many eggs remain.
What FSH actually measures
FSH is not produced by the ovary. It is produced by the pituitary gland.
Early follicle growth begins independently of FSH. FSH supports growth at later stages, including growth of the antral follicle cohort.
As those follicles grow, they produce inhibin B and oestradiol. This feeds back to the pituitary to lower FSH. When inhibin B declines, that feedback weakens and basal FSH rises.
A single FSH reading can fluctuate significantly between and within cycles, which limits what one result can tell us.
Why low AMH and high FSH often appear together
AMH is more sensitive and tends to decline before FSH rises. Basal FSH is a specific but not sensitive marker. Because it fluctuates, a single value can be misleading.
When AMH is low and basal FSH is high on appropriately timed testing, it suggests reduced current follicular activity. In IVF, that helps predict how many eggs may be retrieved. It does not establish that pregnancy is not possible.
What low AMH and high FSH do not establish
If you’ve just been told you have low AMH and high FSH, it’s completely understandable to feel panicked. Many women are told this means they can’t get pregnant, or that time has run out. That is not what these results mean.
For women who don’t have a known diagnosis of infertility, ovarian reserve markers were poor predictors of reproductive potential. They describe how the ovary is behaving right now, not whether this month’s egg can become a pregnancy.
In fact, women with low AMH or high FSH had similar pregnancy rates after 6 and 12 cycles compared to women with normal levels.
And longer term, women defined as having low AMH or high FSH did not have a lower chance of future live birth >3 years after testing and did not have a higher risk of future infertility.
Ovulation needs one egg, not many. These markers describe the current pool and the feedback to the brain — not whether the egg you release this month is capable of resulting in pregnancy.
Which is why results should not be used to deter or refuse treatment.
IVF response is not fertility capacity
IVF depends on recruiting multiple follicles at once. Natural conception and IVF share important requirements — including a competent egg — they simply ask the ovary to do different things in that cycle.
AMH and antral follicle count have been well demonstrated to predict oocyte yield in IVF. Elevated basal FSH is specific but not sensitive, and its variability limits the reliability of a single measurement.
When AMH is low, stimulation may be less efficient. That can mean fewer eggs retrieved in that cycle. In one IVF study, cancellation rates were significantly higher among patients with low AMH, and highest when both markers were abnormal. This was a study-specific finding — individual outcomes vary.
This reflects a limitation of a treatment that relies on multiple follicles, not a verdict on whether pregnancy is possible.
When low AMH and high FSH does make time more important
Age remains the strongest determinant of egg quality. Menstrual history matters — progressive shortening of cycle length or new irregularity can provide context that a single blood test cannot.
A low AMH with high FSH at 32 with regular cycles is a different clinical scenario to the same results at 41 with shortening cycles. The numbers are the same. The biological context is not.
A more proportional way forward
Low AMH and high FSH are not meaningless — but they are not predictive in the way many people are led to believe.
- Useful in IVF planning.
- Limited in predicting natural conception.
- Insufficient on their own to establish that pregnancy is not possible.
Single numbers should not be asked to carry life-changing weight.
Finding a way forward with targeted nutrition
Follicles are metabolically active structures providing the energy and nutrients your egg needs while it is maturing, ready for fertilisation. After ovulation, the follicle becomes the corpus luteum, which produces progesterone to support the endometrium in early pregnancy. The development of an egg towards ovulation takes place over several months.
Sperm development also takes close to three months, which is why preparation is framed around a similar window for both partners.
That window is the period when follicles are drawing on energy, nutrients and hormonal signals to mature — which is why meals, nutrient intake, sleep and metabolic health are central to preparation during this time.
The Now Baby 90-Day Low AMH Nutrition Protocol is professionally designed around that window — nutrient-dense, blood sugar-balancing, and deliberately constructed to support the cellular conditions that egg and sperm development depend on.
